My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Organogenesis Holdings Inc (ORGO)
ORGO nasdaq
United States
Organogenesis Holdings

Organogenesis Holdings Stock Analysis & Ratings

Organogenesis Holdings Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Organogenesis Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


ORGO Stock Stats

Previous Close$11.11
Bid9 x 100
Ask11 x 800
Today’s Range$10.79 - $11.255
52-Week Range$3.44 - $24.34
Average Volume1.12M
Market Cap$1.39B
P/E Ratio19.2
Earnings DateNov 09, 2021

Company Description

Organogenesis Holdings Inc

Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
Drug Manufacturers
Gary S. Gillheeney
85 Dan Road, Canton, MA, 02021, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Organogenesis Holdings’s price range in the past 12 months?
Organogenesis Holdings lowest stock price was $3.44 and its highest was $24.34 in the past 12 months.
    What is Organogenesis Holdings’s market cap?
    Organogenesis Holdings’s market cap is $1.39B.
      What is Organogenesis Holdings’s price target?
      The average price target for Organogenesis Holdings is $27.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $29.00 ,the lowest forecast is $25.00. The average price target represents 149.54% Increase from the current price of $10.82.
        What do analysts say about Organogenesis Holdings?
        Organogenesis Holdings’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
          When is Organogenesis Holdings’s upcoming earnings report date?
          Organogenesis Holdings’s upcoming earnings report date is Nov 09, 2021 which is in 17 days.
            How were Organogenesis Holdings’s earnings last quarter?
            Organogenesis Holdings released its earnings results on Aug 09, 2021. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.058 by $0.092.
              Is Organogenesis Holdings overvalued?
              According to Wall Street analysts Organogenesis Holdings’s price is currently Undervalued.
                Does Organogenesis Holdings pay dividends?
                Organogenesis Holdings does not currently pay dividends.
                What is Organogenesis Holdings’s EPS estimate?
                Organogenesis Holdings’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Organogenesis Holdings have?
                Organogenesis Holdings has 128,580,000 shares outstanding.
                  What happened to Organogenesis Holdings’s price movement after its last earnings report?
                  Organogenesis Holdings reported an EPS of $0.15 in its last earnings report, beating expectations of $0.058. Following the earnings report the stock price went up 1.902%.
                    Which hedge fund is a major shareholder of Organogenesis Holdings?
                    Among the largest hedge funds holding Organogenesis Holdings’s share is Deerfield Management Company, LP. It holds Organogenesis Holdings’s shares valued at 120M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis